Delivery Order SPE2DB24D2205-SPE2DB25FEAHP

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,496.17 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563690644 ATOVAQUONE-PROGUANIL 250-100 100S medical products. The contract has an ultimate completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,456.10, is for the delivery of 4,567,475,756 units of the pharmaceutical product Atovaquone-Proguanil 250-100. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,449.90 firm fixed-price delivery order is for the product Atovaquone-Proguanil 250-100 100s, with an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $14,280.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,475,711 units of Atovaquone-Proguanil 250-100 mg tablets, a malaria medication. The delivery order has a period of performance through March 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $3,939.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug Atovaquone-Proguanil 250-100 100S, which is used for the prevention and treatment of malaria. The contract is not designated as a set-aside and has an ultimate completion date of March 19, 2025. Amerisourcebergen holds a...
This is a $1,222.39 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a medical commodity used for infectious disease prevention. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,862.01 delivery order contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria preventative medication. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of 4,565,910 units of Atovaquone-Proguanil 250-100 mg tablets over a two-year period ending on September 24, 2024. The $9,495.07 firm-fixed-price delivery order is not set aside for any specific business category. Amerisourcebergen, the prime contractor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This is a $2,578.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEAHP
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,723.13 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of atovaquone-proguanil 250-100 100s. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.

Generated 6/30/25, 10:55 AM